Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

OBJECTIVE: To estimate the effectiveness of mRNA vaccines against moderate and severe covid-19 in adults by time since second, third, or fourth doses, and by age and immunocompromised status. DESIGN: Test negative case-control study. SETTING: Hospitals, emergency departments, and urgent care clinics...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferdinands, Jill M, Rao, Suchitra, Dixon, Brian E, Mitchell, Patrick K, DeSilva, Malini B, Irving, Stephanie A, Lewis, Ned, Natarajan, Karthik, Stenehjem, Edward, Grannis, Shaun J, Han, Jungmi, McEvoy, Charlene, Ong, Toan C, Naleway, Allison L, Reese, Sarah E, Embi, Peter J, Dascomb, Kristin, Klein, Nicola P, Griggs, Eric P, Liao, I-Chia, Yang, Duck-Hye, Fadel, William F, Grisel, Nancy, Goddard, Kristin, Patel, Palak, Murthy, Kempapura, Birch, Rebecca, Valvi, Nimish R, Arndorfer, Julie, Zerbo, Ousseny, Dickerson, Monica, Raiyani, Chandni, Williams, Jeremiah, Bozio, Catherine H, Blanton, Lenee, Link-Gelles, Ruth, Barron, Michelle A, Gaglani, Manjusha, Thompson, Mark G, Fireman, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527398/
https://www.ncbi.nlm.nih.gov/pubmed/36191948
http://dx.doi.org/10.1136/bmj-2022-072141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527398/
https://www.ncbi.nlm.nih.gov/pubmed/36191948
http://dx.doi.org/10.1136/bmj-2022-072141

Ejemplares similares